Eurofins Scientific SE Company Description
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.
It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics.
In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing.
Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications.
Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services.
The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
![Eurofins Scientific SE logo](https://img.stockanalysis.com/logos1/PA/ERF.png)
Country | Luxembourg |
Founded | 1987 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 61,798 |
CEO | Gilles Martin |
Contact Details
Address: 23 Val Fleuri Luxembourg City, 1526 Luxembourg | |
Phone | 352 26 18 53 20 |
Website | eurofins.com |
Stock Details
Ticker Symbol | ERF |
Exchange | Euronext Paris |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | FR0014000MR3 |
SIC Code | 8734 |
Key Executives
Name | Position |
---|---|
Dr. Gilles G. Martin Ph.D. | Chairman of the Board and Chief Executive Officer |
Valerie Hanote | Executive Director |
Laurent Lebras | Group Administration and Chief Financial Officer |
Bernard Wang | Head of Investor Relations |
Sandra Hoeylaerts | Chief Human Resources Officer |
David W. Bryant | Senior Vice President of Strategic Business Development North America |
Gabriel Julia | Senior Vice President of Clinical Diagnostics Europe |
Dr. Timothy S. Oostdyk | Executive Vice President of BioPharma, Genomics and Agrosciences Services North America |
Joachim Reichelt | Senior Vice President of Food and Feed Testing Europe |
Yvoine Remy | Senior Vice President of Environment Testing Europe |